CD8A and B-cell chronic lymphocytic leukemia: However, CD8+ T cells showed lower expression of the degranulation marker CD107a in all cohorts, which may indicate that the high number of cells could compensate the reduced cytotoxic activity, thereby explaining the higher DCC observed in the PBMCs from individuals with CLL.